6 Legal And Regulatory Risks Facing Specialty Pharmacies
Law360, New York (March 9, 2017, 10:40 AM EST) -- Carol Ann Poindexter
“Specialty drugs” are a fast growing sector of the pharmaceutical industry and are predicated to represent 50 percent of drug expenditures in the United States by 2020. Specialty drugs are typically dispensed by specialty pharmacies. Although there is no agreed-upon industry definition of “specialty pharmacy,” generally, these pharmacies focus on dispensing and distributing high cost “specialty drugs” prescribed for the treatment complex or chronic medical conditions such as cancer, rheumatoid arthritis, multiple sclerosis, hepatitis C and HIV/AIDS.
Although specialty pharmacies face many of the same legal and regulatory issues that traditional retail pharmacies face,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!